Monocyte-derived dendritic cells: A potential target for therapy in multiple sclerosis (MS)

Clinical and Experimental Immunology

Volumn 123, Issue 2, 2001, Pages 280-287

  Duddy, M E ^a,b   Dickson, G ^a   Hawkins, S A ^a   Armstrong, M A ^a,b  

^a Department of Medicine ^*  (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Dendritic cells; Interferon beta; Methylprednisolone; Monocytes; Multiple sclerosis

Indexed keywords

BETA1 INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; METHYLPREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL;

ADULT; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MONOCYTES; MULTIPLE SCLEROSIS;

EID: 0035111180     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01433.x     Document Type: Article

References (45)

1. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-alpha
2. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells
3. Differentiation of human dendritic cells from monocytes in vitro
4. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes
5. Glucocorticoids affect human dendritic cell differentiation and maturation
6. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen presenting-cells
7. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
8. Dendritic cells as the terminal stage of monocyte differentiation
9. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat
10. Induction of autoimmunity with dendritic cells: Studies on thyroiditis in mice
11. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue
12. Dendritic cells
13. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes
14. Steroids in multiple sclerosis
15. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
16. How can dendritic cells cause autoimmune disease?
17. Monocytes from systemic lupus erythematosus patients are severely altered in phenotype and lineage flexibility
18. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines
19. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
20. A novel cell-surface molecule expressed by human interdigitating reticulum cells. Langerhans cells and activated lymphocytes is a new member of the immunoglobulin superfamily
21. Methylprednisolone infusion during acute exacerbation of MS: Plasma and CSF concentrations
22. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo
23. A novel mechanism of glucocorticoid-induced immune suppression: The inhibition of T cell-mediated terminal maturation of a murine dendritic cell line
24. Glucocorticoids inhibit bioactive IL-12p70 production by in vitrogenerated dendritic cells without affecting their T cell stimulatory potential
25. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10
26. Type I IFNs enhance the terminal differentiation of dendritic cells
27. Serum interferon-beta-1a (Avonex) levels following intramuscular injection in relapsing-remitting MS patients
28. Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis
29. Type 1 IFNs inhibit dendritic cell IL-12 production and Th1 cell development
30. IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells
31. Interleukin-10 prevents the generation of dendritic cells from human blood peripheral mononuclear cells cultured with interleukin-4 and granulocyte/macrophage colony stimulating factor
32. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step
33. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
34. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
35. Immunosuppression by glucocorticoids: Inhibition of NF κB activity through induction of IκB synthesis
36. Interleukin (IL)-10 inhibits nuclear factor kappaB (NF-κB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
37. How cells respond to interferons
38. Interleukin-10 inhibits expression of both interferon-α and interferon-γ genes by suppressing tyrosine phosphorylation of STAT1
39. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
40. The role of microglia and macrophages in the pathophysiology of the CNS
41. Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain
42. Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat
43. Allografts of CNS tissues possess a blood brain barrier: III. Neuropathological, methodological and immunological considerations
44. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii
45. Distribution and phenotype of dendritic cells and resident tissue macrophages in dura mater, leptomehinges and choroid plexus of the rat brain demonstrated by whole mount preparations